Dr. Rudra has recently joined Washington University in St.
Louis, MO from UTMB, where
he has been an assistant professor in the Department of Pharmacology and
Toxicology. Previously, he was a postdoctoral fellow at the University
of Chicago in the Department of Surgery. At UTMB, he
was a member of the Sealy Institute for Vaccine Sciences, the Center for
Addiction Research and of the Human Pathophysiology and Translational
Research Graduate Program.
Among Dr. Rudra's research interests includes the development of nanoscale biomaterials such as
nanofibers, nanoparticles, virus-like particles, and hydrogels for
engaging the immune system to induce protective antibody and
cell-mediated immune responses against diseases such as tuberculosis,
melanoma, and flavivirus infections (West Nile and Zika). Dr. Rudra also
investigates the development of vaccines against drugs of addiction
such as cocaine.
Search NCBI for Dr. Rudra's publications.